All Stories

  1. Translational potential of natural bioactive-based formulations in atopic dermatitis: Current insights

    Article • Medicine in Novel Technology and Devices, December 2025, Elsevier

    Dr RAJENDRA AWASTHI

  2. Berberine Hydrochloride and Caffeic Acid Loaded Dual Delivery PLGA Nanoparticles: Optimization, In Vitro, and In Ovo Studies

    Article • BioNanoScience, September 2025, Springer Science + Business Media

    Dr RAJENDRA AWASTHI

  3. Bovine Serum Albumin-Based Nanoparticles Embedded In Situ Nasal Gel for Brain Delivery of Donepezil: In Vitro and In Vivo Studies

    Article • BioNanoScience, August 2025, Springer Science + Business Media

    Dr RAJENDRA AWASTHI

  4. PLGA nanoparticles as promising drug delivery carrier: the future of skin cancer treatment

    Article • Journal of Umm Al-Qura University for Applied Sciences, June 2025, Springer Science + Business Media

    Dr RAJENDRA AWASTHI

  5. Enzymatic Hydrolysis of Perilla Seed Protein: Optimization, Physico-Functional Evaluation, and Structural Characterization

    Article • Food Analytical Methods, May 2025, Springer Science + Business Media

    Dr RAJENDRA AWASTHI, Pramod K Prabhakar

  6. Vetiver, Vetiveria zizanioides (L.) Nash: Biotechnology, Biorefineries, and the Production of Volatile Phytochemicals

    Article • Plants, May 2025, MDPI AG

    Dr RAJENDRA AWASTHI

  7. Iron Homeostasis and Metabolism During Pregnancy: Exploring Innovative Drug Delivery Approaches for Treating Iron Deficiency Anemia in Pregnant Women

    Article • Archiv der Pharmazie, May 2025, Wiley

    Dr RAJENDRA AWASTHI

  8. Topical transferosomal gel of berberine HCl and diacerein reduced TNF-α and IL-17A levels and reduced epidermal thickness in imiquimod-induced psoriatic BALB/c mice

    Article • Journal of Drug Delivery Science and Technology, April 2025, Elsevier

    Dr RAJENDRA AWASTHI

  9. Curcumin-loaded nanoemulsion for acute lung injury treatment via nebulization: Formulation, optimization and in vivo studies

    Article • ADMET & DMPK, March 2025, International Association of Physical Chemists (IAPC)

    Dr RAJENDRA AWASTHI

  10. Optimization of ultrasound mediated extraction of perilla protein isolate: study of ultrasonication effect on amino acid profile and functional characteristics

    Article • Journal of Food Measurement & Characterization, February 2025, Springer Science + Business Media

    Dr RAJENDRA AWASTHI

  11. Unveiling the role of nanoparticle-based therapeutic strategies for pulmonary drug delivery

    Article • Journal of Drug Delivery Science and Technology, February 2025, Elsevier

    Dr RAJENDRA AWASTHI

  12. Surface-modified liposomal in-situ nasal gel enhances brain targeting of berberine hydrochloride for Alzheimer’s therapy: optimization and in vivo studies

    Article • Journal of Liposome Research, November 2024, Taylor & Francis

    Dr RAJENDRA AWASTHI

  13. Estimation of Rheological Coefficients of Acacia nilotica Gum: A Versatile Biopolymer for Biomedical and Food Industries

    Article • Current Nutrition & Food Science, October 2024, Bentham Science Publishers

    Dr RAJENDRA AWASTHI, Rishabha Malviya

  14. Synthesis of Novel Acrylamide Graft Copolymer of Acacia nilotica Gum for the Stabilization of Melatonin Nanoparticles for Improved Therapeutic Effect: Optimization Using (3)2 Factorial Design

    Article • Assay and Drug Development Technologies, September 2024, Mary Ann Liebert Inc

    Dr RAJENDRA AWASTHI

  15. Development of Epigallocatechin and Ascorbic Acid Dual Delivery Transferosomes for Managing Alzheimer’s Disease: In Vitro and in Vivo Studies

    Article • ACS Omega, August 2024, American Chemical Society (ACS)

    Dr RAJENDRA AWASTHI

  16. Monoclonal Antibodies and Antibody-drug Conjugates as Emerging Therapeutics for Breast Cancer Treatment

    Article • Current Drug Delivery, August 2024, Bentham Science Publishers

    Dr RAJENDRA AWASTHI, Dr Gaurav Gupta, Vimal Arora, Swati Saini

  17. Optimizing gefitinib nanoliposomes by Box-Behnken design and coating with chitosan: A sequential approach for enhanced drug delivery

    Article • ADMET & DMPK, July 2024, International Association of Physical Chemists (IAPC)

    Dr RAJENDRA AWASTHI

  18. Harnessing nanotechnology for enhanced delivery of erlotinib: a dynamic duo in cancer treatment

    Article • Beni-Suef University Journal of Basic and Applied Sciences, July 2024, Springer Science + Business Media

    Mr. Rajat Goyal, Dr RAJENDRA AWASTHI

  19. Exploring the Potential of Pectin for Gastro Retentive Drug Delivery Systems: From Orchard to Drug Delivery

    Article • Current Drug Therapy, July 2024, Bentham Science Publishers

    Dr RAJENDRA AWASTHI

  20. Essential Oils

    Article • July 2024, Taylor & Francis

    Dr RAJENDRA AWASTHI

  21. Formulation and optimization of electrospun nanofiber films for ultrafast delivery of domperidone: In vitro and in-vivo characterization

    Article • Journal of Drug Delivery Science and Technology, May 2024, Elsevier

    Dr RAJENDRA AWASTHI

  22. Berberine HCl and diacerein loaded dual delivery transferosomes: Formulation and optimization using Box-Behnken design

    Article • ADMET & DMPK, April 2024, International Association of Physical Chemists (IAPC)

    Dr RAJENDRA AWASTHI

  23. Nano-green: Harnessing the potential of plant extracts for sustainable antimicrobial metallic nanoparticles

    Article • Journal of Drug Delivery Science and Technology, April 2024, Elsevier

    Dr RAJENDRA AWASTHI

  24. Nanoliposomes Embedded Nanocochleates for Codelivery of Artemether and Lumefantrine: An In Vitro and In Vivo Study

    Article • Assay and Drug Development Technologies, March 2024, Mary Ann Liebert Inc

    Dr RAJENDRA AWASTHI

  25. STAR particles as potential game-changer in drug delivery and biological processes: Moving beyond conventional nanoparticles

    Article • Journal of Drug Delivery Science and Technology, March 2024, Elsevier

    Dr RAJENDRA AWASTHI

  26. Biogenic metallic nanoparticles as game-changers in targeted cancer therapy: recent innovations and prospects

    Article • Future Journal of Pharmaceutical Sciences, February 2024, Springer Science + Business Media

    Dr RAJENDRA AWASTHI

  27. Non-coding RNAs in Regulation of Protein Aggregation and Clearance Pathways: Current Perspectives Towards Alzheimer's Research and Therapy

    Article • Current Gene Therapy, February 2024, Bentham Science Publishers

    Rishabha Malviya, Dr RAJENDRA AWASTHI

  28. Disease X: Beyond Fear, Toward Preparedness

    Article • Infectious Disorders - Drug Targets, January 2024, Bentham Science Publishers

    Dr RAJENDRA AWASTHI

  29. In vitro profiling and molecular dynamics simulation studies of berberine loaded MCM-41 mesoporous silica nanoparticles to prevent neuronal apoptosis

    Article • Nanoscale Advances, January 2024, Royal Society of Chemistry

    Dr RAJENDRA AWASTHI

  30. Neuroprotection induced by sulphoraphane in central nervous system disorders

    Article • January 2024, Elsevier

    Dr RAJENDRA AWASTHI

  31. Letter to the Editor: Concerns Regarding Ethical Issues in Reviewer Recommendations for Citations

    Article • Assay and Drug Development Technologies, December 2023, Mary Ann Liebert Inc

    Dr RAJENDRA AWASTHI

  32. Genetic Causes of Alzheimer’s Disease and the Neuroprotective Role of Melatonin in its Management

    Article • CNS & Neurological Disorders - Drug Targets, November 2023, Bentham Science Publishers

    Dr RAJENDRA AWASTHI

  33. Unlocking new dimensions in rheumatoid arthritis therapy: Harnessing the power of lipid based vesicles beyond traditional therapies

    Article • Journal of Drug Delivery Science and Technology, November 2023, Elsevier

    Dr RAJENDRA AWASTHI

  34. Sorafenib tosylate-loaded nanosuspension: preparation, optimization, and in vitro cytotoxicity study against human HepG2 carcinoma cells

    Article • Journal of Chemotherapy, October 2023, Taylor & Francis

    Dr RAJENDRA AWASTHI

  35. Biosensors for Neurodegenerative Diseases

    Article • September 2023, Bentham Science Publishers

    Anand Maurya, Dr RAJENDRA AWASTHI

  36. Emerging Applications of Polymeric Nanoparticles in Tumor Targeting

    Article • Current Nanoscience, September 2023, Bentham Science Publishers

    Dr Dinesh Kumar Chellappan, Parteek Prasher, Dr Monica gulati, Dr RAJENDRA AWASTHI, Dr Gaurav Gupta

  37. Nose-to-brain drug delivery: Challenges and progress towards brain targeting in the treatment of neurological disorders

    Article • Journal of Drug Delivery Science and Technology, September 2023, Elsevier

    Dr Giriraj T Kulkarni, Dr RAJENDRA AWASTHI

  38. Correction to “Lipid-Coated MCM-41 Mesoporous Silica Nanoparticles Loaded with Berberine Improved Inhibition of Acetylcholine Esterase and Amyloid Formation”

    Article • ACS Biomaterials Science & Engineering, July 2023, American Chemical Society (ACS)

    Dr RAJENDRA AWASTHI

  39. Breakthroughs and bottlenecks of psoriasis therapy: Emerging trends and advances in lipid based nano-drug delivery platforms for dermal and transdermal drug delivery

    Article • Journal of Drug Delivery Science and Technology, June 2023, Elsevier

    Dr RAJENDRA AWASTHI

  40. Preparation and Optimization of Liposome Containing Thermosensitive In Situ Nasal Hydrogel System for Brain Delivery of Sumatriptan Succinate

    Article • Assay and Drug Development Technologies, January 2023, Mary Ann Liebert Inc

    Dr RAJENDRA AWASTHI

  41. Sorafenib tosylate loaded superparamagnetic nanoparticles: Development, optimization and cytotoxicity analysis on HepG2 human hepatocellular carcinoma cell line

    Article • Journal of Drug Delivery Science and Technology, January 2023, Elsevier

    Dr RAJENDRA AWASTHI

  42. Rational design of linkers in polymer–drug conjugates

    Article • January 2023, Elsevier

    Dr RAJENDRA AWASTHI

  43. Nanovaccine: A Hope to Triumph the Battle Against Novel Coronavirus Disease 2019 (COVID-19)

    Article • Recent Patents on Nanotechnology, December 2022, Bentham Science Publishers

    Dr RAJENDRA AWASTHI

  44. Intranasally Co-administered Berberine and Curcumin Loaded in Transfersomal Vesicles Improved Inhibition of Amyloid Formation and BACE-1

    Article • ACS Omega, November 2022, American Chemical Society (ACS)

    Dr RAJENDRA AWASTHI

  45. Hydrogels for localized drug delivery: A special emphasis on dermatologic applications

    Article • Dermatologic Therapy, September 2022, Wiley

    shammy jindal, Dr Giriraj T Kulkarni, Dr RAJENDRA AWASTHI

  46. Recent developments, challenges and future prospects in advanced drug delivery systems in the management of tuberculosis

    Article • Journal of Drug Delivery Science and Technology, September 2022, Elsevier

    Dr Keshav Raj Paudel, Dr RAJENDRA AWASTHI, Dr MEHNAZ KAMAL

  47. Formulation and Characterization of Nanostructured Lipid Carriers of Rizatriptan Benzoate-Loaded In Situ Nasal Gel for Brain Targeting

    Article • Assay and Drug Development Technologies, July 2022, Mary Ann Liebert Inc

    Dr RAJENDRA AWASTHI

  48. Evolution of Solid Dispersion Technology: Solubility Enhancement Using Hydroxypropyl Methylcellulose Acetate Succinate: Myth or Reality?

    Article • Assay and Drug Development Technologies, June 2022, Mary Ann Liebert Inc

    Dr RAJENDRA AWASTHI

  49. Precipitation Titration

    Article • February 2022, Bentham Science Publishers

    shammy jindal, Dr. Kamya Goyal, Dr RAJENDRA AWASTHI

  50. Oxygen Flask Combustion Method

    Article • February 2022, Bentham Science Publishers

    Dr RAJENDRA AWASTHI, shammy jindal, Dr. Kamya Goyal

  51. Kjeldahl Method

    Article • February 2022, Bentham Science Publishers

    Dr RAJENDRA AWASTHI, shammy jindal, Dr. Kamya Goyal

  52. Diazotization Method

    Article • February 2022, Bentham Science Publishers

    Dr RAJENDRA AWASTHI, shammy jindal, Dr. Kamya Goyal

  53. Preparation and Evaluation of Gefitinib Containing Nanoliposomal Formulation for Lung Cancer Therapy

    Article • BioNanoScience, January 2022, Springer Science + Business Media

    Dr RAJENDRA AWASTHI

  54. Ethnopharmacological reports on herbs used in the management of tuberculosis

    Article • January 2022, Elsevier

    Dr RAJENDRA AWASTHI

  55. Nanosuspensions - An Update on Recent Patents, Methods of Preparation, and Evaluation Parameters

    Article • Recent Patents on Nanotechnology, October 2021, Bentham Science Publishers

    Dr RAJENDRA AWASTHI, Saurabh Satija, Alaa Aljabali, Dr Dinesh Kumar Chellappan

  56. Efficacy of Ulinastatin and Sulforaphane Alone or in Combination in Rat Model of Streptozotocin Diabetes Induced Vascular Dementia

    Article • Clinical Psychopharmacology and Neuroscience, August 2021, Korean College of Neuropsychopharmacology (KAMJE)

    Dr Giriraj T Kulkarni, Dr RAJENDRA AWASTHI

  57. Lipid-Coated MCM-41 Mesoporous Silica Nanoparticles Loaded with Berberine Improved Inhibition of Acetylcholine Esterase and Amyloid Formation

    Article • ACS Biomaterials Science & Engineering, July 2021, American Chemical Society (ACS)

    Dr RAJENDRA AWASTHI

  58. Efavirenz Loaded Mixed Polymeric Micelles: Formulation, Optimization, and In Vitro Characterization

    Article • Assay and Drug Development Technologies, July 2021, Mary Ann Liebert Inc

    Dr RAJENDRA AWASTHI

  59. Stabilization of Etoricoxib Nanosuspension Using Acacia chundra Gum and Copolymers: Preparation, Characterization, and In Vitro Cytotoxic Study

    Article • Assay and Drug Development Technologies, July 2021, Mary Ann Liebert Inc

    Dr RAJENDRA AWASTHI

  60. Behavioral and biochemical investigations to explore the efficacy of quercetin and folacin in experimental diabetes induced vascular endothelium dysfunction and associated dementia in rats

    Article • Journal of Basic and Clinical Physiology and Pharmacology, June 2021, De Gruyter

    Dr Giriraj T Kulkarni, Dr RAJENDRA AWASTHI

  61. Therapeutic Potential of Phytoconstituents in Management of Alzheimer’s Disease

    Article • Evidence-based Complementary and Alternative Medicine, June 2021, Hindawi Publishing Corporation

    Dr RAJENDRA AWASTHI

  62. Albumin-Coated Mesoporous Silica Nanoparticles of Docetaxel: Preparation, Characterization, and Pharmacokinetic Evaluation

    Article • Assay and Drug Development Technologies, May 2021, Mary Ann Liebert Inc

    Dr RAJENDRA AWASTHI

  63. Lipid Nanoparticles as Carriers for Bioactive Delivery

    Article • Frontiers in Chemistry, April 2021, Frontiers

    Dr Giriraj T Kulkarni, Dr RAJENDRA AWASTHI

  64. Chalcones: A review on synthesis and pharmacological activities

    Article • Journal of Applied Biology & Biotechnology, March 2021, Journal of Applied Pharmaceutical Science

    RAJWINDER KAUR, Dr RAJENDRA AWASTHI

  65. Isolation, characterization and evaluation of anti-proliferative properties of andrographolide isolated from Andrographis paniculata on cultured HaCaT cells

    Article • March 2021, Index Copernicus

    Dr Giriraj T Kulkarni, Dr RAJENDRA AWASTHI

  66. Cocrystals of Apixaban with Improved Solubility and Permeability: Formulation, Physicochemical Characterization, Pharmacokinetic Evaluation, and Computational Studies

    Article • Assay and Drug Development Technologies, March 2021, Mary Ann Liebert Inc

    Dr RAJENDRA AWASTHI

  67. Preparation and in vitro evaluation of Tacrolimus loaded liposomal vesicles by two methods: A comparative study

    Article • Journal of Research in Pharmacy, January 2021, ASOS Yayinevi

    Dr Giriraj T Kulkarni, Dr RAJENDRA AWASTHI

  68. Nanocarriers for protein and peptide delivery: Recent advances and progress

    Article • Journal of Research in Pharmacy, January 2021, ASOS Yayinevi

    Dr Giriraj T Kulkarni, Dr RAJENDRA AWASTHI

  69. Immunotherapy for Alzheimer’s Disease: Current Scenario and Future Perspectives

    Article • The Journal of Prevention of Alzheimer s Disease, January 2021, SERDI

    DR VIJAY JAGDISH UPADHYE VIJAY JAGDISH UPADHYE, Dr RAJENDRA AWASTHI

  70. Formulation and evaluation of nano structured lipid carriers for intranasal delivery of Buspirone hydrochloride

    Article • Research Journal of Pharmacy and Technology, January 2021, A and V Publications

    Dr RAJENDRA AWASTHI

  71. Therapeutic implications of inorganic nanoparticles for codelivery of bioactives in cancer therapy

    Article • January 2021, Elsevier

    Dr RAJENDRA AWASTHI

  72. Treatment and Prevention of Osteoporosis during COVID-19 Outbreak: Management and Adherence to Treatment Guidelines

    Article • The Open Public Health Journal, December 2020, Bentham Science Publishers

    Dr RAJENDRA AWASTHI

  73. Solid lipid nanoparticles containing anti-tubercular drugs attenuate the Mycobacterium marinum infection

    Article • Tuberculosis, December 2020, Elsevier

    Dr Keshav Raj Paudel, Dr RAJENDRA AWASTHI

  74. Artificial Intelligence, Blockchain, and Internet of Medical Things: New Technologies in Detecting, Preventing, and Controlling of Emergent Diseases

    Article • November 2020, Springer Science + Business Media

    Dr RAJENDRA AWASTHI

  75. Biofabrication: An interesting tool to create in vitro model for COVID-19 drug targets

    Article • Medical Hypotheses, November 2020, Elsevier

    Dr Giriraj T Kulkarni, Dr RAJENDRA AWASTHI

  76. Topical delivery of Tacrolimus using liposome containing gel: An emerging and synergistic approach in management of psoriasis

    Article • Medical Hypotheses, September 2020, Elsevier

    Dr Giriraj T Kulkarni, Dr RAJENDRA AWASTHI

  77. Severity and risk ofCOVID‐19 in cancer patients: An evidence‐based learning

    Article • Dermatologic Therapy, July 2020, Hindawi Publishing Corporation

    Dr RAJENDRA AWASTHI

  78. Molecular mechanisms of action of naringenin in chronic airway diseases

    Article • European Journal of Pharmacology, July 2020, Elsevier

    Dr Keshav Raj Paudel, Conjoint Professor Peter Wark, Dr RAJENDRA AWASTHI

  79. Novel corona virus disease ( COVID ‐19) and ophthalmic manifestations: Clinical evidences

    Article • Dermatologic Therapy, June 2020, Hindawi Publishing Corporation

    Dr RAJENDRA AWASTHI

  80. Novel coronavirus disease 2019 (COVID‐19) and neurodegenerative disorders

    Article • Dermatologic Therapy, May 2020, Hindawi Publishing Corporation

    Dr RAJENDRA AWASTHI

  81. Formulation and In Vitro Evaluation of Casein Nanoparticles as Carrier for Celecoxib

    Article • Advanced Pharmaceutical Bulletin, May 2020, MaadRayan Publishing Company

    Dr RAJENDRA AWASTHI

  82. Development of Mucoadhesive Buccal Drug Delivery System of Propranolol Hydrochloride Using Aster ericoides Mucilage

    Article • Drug Delivery Letters, April 2020, Bentham Science Publishers

    Dr Giriraj T Kulkarni, Dr RAJENDRA AWASTHI, Ankaj Kaundal

  83. Formulation, optimization, and in vitro evaluation of nanostructured lipid carriers for topical delivery of Apremilast

    Article • Dermatologic Therapy, April 2020, Hindawi Publishing Corporation

    Dr RAJENDRA AWASTHI

  84. Lipid-PLGA hybrid nanoparticles of paclitaxel: Preparation, characterization, in vitro and in vivo evaluation

    Article • Materials Science and Engineering C, April 2020, Elsevier

    Dr RAJENDRA AWASTHI

  85. Emerging trends in nanomedicine for topical delivery in skin disorders: Current and translational approaches

    Article • Dermatologic Therapy, March 2020, Hindawi Publishing Corporation

    Dr RAJENDRA AWASTHI

  86. Formulation, Optimization, and Evaluation of Ketoconazole Loaded Nanostructured Lipid Carrier Gel for Topical Delivery

    Article • Drug Delivery Letters, February 2020, Bentham Science Publishers

    Dr RAJENDRA AWASTHI

  87. Role of TREM2 in Alzheimer's Disease and its Consequences on β- Amyloid, Tau and Neurofibrillary Tangles

    Article • Current Alzheimer Research, January 2020, Bentham Science Publishers

    Dr RAJENDRA AWASTHI, Abhimanyu Thakur, Dr Giriraj T Kulkarni, Mr. Anurag Kumar Singh , Anand Maurya

  88. Nanoantibiotic Formulations to Combat Antibiotic Resistance - Old Wine in a New Bottle

    Article • Recent Patents on Drug Delivery & Formulation, January 2020, Bentham Science Publishers

    Dr Giriraj T Kulkarni, Dr RAJENDRA AWASTHI

  89. Formulation, optimization and in vitro evaluation of nanostructured lipid carriers for topical delivery of apremilast

    Article • January 2020, Beilstein Institut

    Dr RAJENDRA AWASTHI

  90. Therapeutic Benefits of Saffron in Brain Diseases

    Article • January 2020, Elsevier

    Dr Giriraj T Kulkarni, Dr RAJENDRA AWASTHI

  91. Inorganic clay nanocomposite system for improved cholinesterase inhibition and brain pharmacokinetics of donepezil

    Article • Drug Development and Industrial Pharmacy, December 2019, Taylor & Francis

    Mr. Anurag Kumar Singh , Dr RAJENDRA AWASTHI

  92. Formulation and evaluation of solid self-microemulsifying drug delivery system for azilsartan medoxomil

    Article • International Journal of Polymeric Materials, November 2019, Taylor & Francis

    Dr RAJENDRA AWASTHI

  93. Grewia asiatica mucilage: A smart gelling polymeric material for pharmaceutical applications - in vitro studies

    Article • Current Materials Science, November 2019, Bentham Science Publishers

    Dr RAJENDRA AWASTHI, Dr Giriraj T Kulkarni

  94. Berberine: A Plant-derived Alkaloid with Therapeutic Potential to Combat Alzheimer’s disease

    Article • Central Nervous System Agents in Medicinal Chemistry, October 2019, Bentham Science Publishers

    Mr. Anurag Kumar Singh , Dr Giriraj T Kulkarni, Dr RAJENDRA AWASTHI

  95. Plant Derived Polysaccharides as Pharmaceutical Excipients: An Overview

    Article • September 2019, Springer Science + Business Media

    Dr Giriraj T Kulkarni, Dr RAJENDRA AWASTHI

  96. Oligonucleotide therapy: An emerging focus area for drug delivery in chronic inflammatory respiratory diseases

    Article • Chemico-Biological Interactions, August 2019, Elsevier

    Dr RAJENDRA AWASTHI

  97. The potential of siRNA based drug delivery in respiratory disorders: Recent advances and progress

    Article • Drug Development Research, July 2019, Wiley

    Dr RAJENDRA AWASTHI

  98. Formulation and solid state characterization of carboxylic acid-based co-crystals of tinidazole: An approach to enhance solubility

    Article • Polymers in Medicine, April 2019, Wroclaw Medical University

    Dr RAJENDRA AWASTHI

  99. Strategic use of nanotechnology in drug targeting and its consequences on human health: A focused review

    Article • Interventional Medicine and Applied Science, March 2019, Akademiai Kiado

    Dr RAJENDRA AWASTHI, Mr. Anurag Kumar Singh , Dr Giriraj T Kulkarni

  100. Therapeutic strategies for targeting non-coding RNAs with special emphasis on novel delivery systems

    Article • Non-coding RNA Investigation, March 2019, AME Publishing Company

    Dr RAJENDRA AWASTHI

  101. Increasing complexity and interactions of oxidative stress in chronic respiratory diseases: An emerging need for novel drug delivery systems

    Article • Chemico-Biological Interactions, February 2019, Elsevier

    Dr RAJENDRA AWASTHI

  102. Preparation, characterization and in vitro evaluation of tablets containing microwave-assisted solid dispersions of apremilast

    Article • Polymers in Medicine, January 2019, Wroclaw Medical University

    Dr RAJENDRA AWASTHI

  103. Antibacterial and In Vitro Growth Inhibition Study of Struvite Urinary Stones Using Oxalis corniculata Linn. Leaf Extract and its Biofabricated Silver Nanoparticles

    Article • Recent Patents on Drug Delivery & Formulation, January 2019, Bentham Science Publishers

    Dr RAJENDRA AWASTHI, Himaja Malipeddi

  104. Aqueous Extract of Wood Ear Mushroom, Auricularia polytricha (Agaricomycetes), Demonstrated Antiepileptic Activity against Seizure Induced by Maximal Electroshock and Isoniazid in Experimental Animals

    Article • International Journal of Medicinal Mushrooms, January 2019, Begell House

    Dr RAJENDRA AWASTHI

  105. Skin Targeting of Oxiconazole Nitrate Loaded Nanostructured Lipid- Carrier Gel for Fungal Infections

    Article • Pharmaceutical Nanotechnology, December 2018, Bentham Science Publishers

    Dr RAJENDRA AWASTHI, Kishore Gujar

  106. Novel drug delivery approaches in treating pulmonary fibrosis

    Article • Panminerva Medica, December 2018, Edizioni Minerva Medica

    Dr RAJENDRA AWASTHI

  107. Nanoparticles in Cancer Treatment: Opportunities and Obstacles

    Article • Current Drug Targets, September 2018, Bentham Science Publishers

    Dr RAJENDRA AWASTHI, Phil Hansbro

  108. Evaluation of an Amplified ATP Bioluminescence Method for Rapid Sterility Testing of Large Volume Parenteral

    Article • Journal of Pharmaceutical Innovation, September 2018, Springer Science + Business Media

    Dr RAJENDRA AWASTHI

  109. Why is there an emerging need to look for a suitable drug delivery platform in targeting and regulating microbiota?

    Article • Panminerva Medica, September 2018, Edizioni Minerva Medica

    Dr RAJENDRA AWASTHI

  110. Formulation and evaluation of controlled-release matrix systems of ciprofloxacin

    Article • Polymers in Medicine, June 2018, Wroclaw Medical University

    Dr RAJENDRA AWASTHI

  111. Improving dissolution profile of poorly water-soluble drug using non-ordered mesoporous silica

    Article • Marmara Pharmaceutical Journal, April 2018, Marmara Pharmaceutical Journal

    Dr RAJENDRA AWASTHI

  112. Matrix-assisted laser desorption ionization–time of flight mass spectrometry for identification of bacteria isolated from pharmaceutical clean rooms

    Article • Interventional Medicine and Applied Science, March 2018, Akademiai Kiado

    Dr RAJENDRA AWASTHI

  113. Application of Chitosan and its Derivatives in Nanocarrier Based Pulmonary Drug Delivery Systems

    Article • Pharmaceutical Nanotechnology, January 2018, Bentham Science Publishers

    Dr RAJENDRA AWASTHI

  114. PHYTOSOME: MOST SIGNIFICANT TOOL FOR HERBAL DRUG DELIVERY TO ENHANCE THE THERAPEUTIC BENEFITS OF PHYTOCONSTITUENTS

    Article • Journal of Drug Delivery and Therapeutics, January 2018, Society of Pharmaceutical Tecnocrats

    Dr RAJENDRA AWASTHI

  115. Evaluating the Potential, Applicability, and Effectiveness of Ozone Sterilization Process for Medical Devices

    Article • Journal of Pharmaceutical Innovation, January 2018, Springer Science + Business Media

    Dr RAJENDRA AWASTHI

  116. An Overview of Circular RNAs

    Article • January 2018, Springer Science + Business Media

    Mr. Anurag Kumar Singh , Dr RAJENDRA AWASTHI

  117. Formulation, Characterization and In-vitro Evaluation of Fast Dissolv ing Tablets Containing Gliclazide Hydrotropic Solid Dispersions

    Article • Recent Patents on Drug Delivery & Formulation, December 2017, Bentham Science Publishers

    Dr RAJENDRA AWASTHI

  118. Performance Survey and Comparison Between Rapid Sterility Testing Method and Pharmacopoeia Sterility Test

    Article • Journal of Pharmaceutical Innovation, December 2017, Springer Science + Business Media

    Dr RAJENDRA AWASTHI

  119. Improving the solubility of nevirapine using a hydrotropy and mixed hydrotropy based solid dispersion approach

    Article • Polymers in Medicine, December 2017, Wroclaw Medical University

    Dr RAJENDRA AWASTHI

  120. Formation of struvite urinary stones and approaches towards the inhibition—A review

    Article • Biomedicine & Pharmacotherapy, December 2017, Elsevier

    Dr RAJENDRA AWASTHI

  121. Therapeutic prospects of microRNAs in cancer treatment through nanotechnology

    Article • Drug Delivery and Translational Research, November 2017, Springer Science + Business Media

    Dr RAJENDRA AWASTHI

  122. Potential therapeutic activity of Phlogacanthus thyrsiformis Hardow (Mabb) flower extract and its biofabricated silver nanoparticles against chemically induced urolithiasis in male Wistar rats

    Article • International Journal of Biological Macromolecules, October 2017, Elsevier

    Dr RAJENDRA AWASTHI

  123. Dual crosslinked pectin–alginate network as sustained release hydrophilic matrix for repaglinide

    Article • International Journal of Biological Macromolecules, April 2017, Elsevier

    Dr Giriraj T Kulkarni, Dr RAJENDRA AWASTHI

  124. Hydrogel based drug delivery systems: A review with special emphasis on challenges associated with decontamination of hydrogels and biomaterials

    Article • Current Drug Delivery, December 2016, Bentham Science Publishers

    Dr RAJENDRA AWASTHI

  125. Opportunities and Challenges in Nano-structure Mediated Drug Delivery: Where Do We Stand?

    Article • Current Nanomedicine, October 2016, Bentham Science Publishers

    Dr RAJENDRA AWASTHI, Dr Giriraj T Kulkarni

  126. Preparation and characterization of metoprolol tartrate containing matrix type transdermal drug delivery system

    Article • Drug Delivery and Translational Research, September 2016, Springer Science + Business Media

    Dr RAJENDRA AWASTHI

  127. Formulation and evaluation of controlled release ethylcellulose and polyethylene glycol microspheres containing metoprolol tartrate

    Article • Interventional Medicine and Applied Science, June 2016, Akademiai Kiado

    Dr RAJENDRA AWASTHI

  128. Norfloxacin and metronidazole topical formulations for effective treatment of bacterial infections and burn wounds

    Article • Interventional Medicine and Applied Science, June 2016, Akademiai Kiado

    Dr RAJENDRA AWASTHI

  129. Development and characterization of solid dispersion-microsphere controlled release system for poorly water-soluble drug

    Article • Drug Delivery and Translational Research, June 2016, Springer Science + Business Media

    Dr RAJENDRA AWASTHI

  130. Investigation on binding properties of Grewia asiatica mucilage in tablet formulations

    Article • Marmara Pharmaceutical Journal, May 2016, Marmara Pharmaceutical Journal

    Dr Giriraj T Kulkarni, Dr RAJENDRA AWASTHI

  131. Piperine containing floating microspheres: an approach for drug targeting to the upper gastrointestinal tract

    Article • Drug Delivery and Translational Research, February 2016, Springer Science + Business Media

    Dr RAJENDRA AWASTHI

  132. Gastroretentive floating tablets: An investigation of excipients effect on tablet properties

    Article • Marmara Pharmaceutical Journal, February 2016, Marmara Pharmaceutical Journal

    Dr RAJENDRA AWASTHI

  133. Development of Ocular Delivery System for Glaucoma Therapy Using Natural Hydrogel as Film Forming Agent and Release Modifier

    Article • Polymers in Medicine, January 2016, Wroclaw Medical University

    Dr Giriraj T Kulkarni, Dr RAJENDRA AWASTHI

  134. Development of Bilayer Tablets with Modified Release of Selected Incompatible Drugs

    Article • Polymers in Medicine, January 2016, Wroclaw Medical University

    Dr RAJENDRA AWASTHI

  135. Frontier lipid-based carrier systems for drug targeting: A laconic review on niosomes

    Article • Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, May 2015, Bentham Science Publishers

    Dr RAJENDRA AWASTHI

  136. Frontier Lipid-Based Carrier Systems for Drug Targeting: A Laconic Review on Niosomes

    Article • Pharmaceutical Nanotechnology, February 2015, Bentham Science Publishers

    Dr RAJENDRA AWASTHI, Dr Giriraj T Kulkarni

  137. Development of Metronidazole-Loaded Colon-Targeted Microparticulate Drug Delivery System

    Article • Polymers in Medicine, January 2015, Wroclaw Medical University

    Dr RAJENDRA AWASTHI

  138. Development of Dehydration-Rehydration Liposomal System Using Film Hydration Technique Followed by Sonication

    Article • Current Drug Delivery, December 2014, Bentham Science Publishers

    Dr RAJENDRA AWASTHI

  139. Decades of research in drug targeting to the upper gastrointestinal tract using gastroretention technologies: where do we stand?

    Article • Drug Delivery, July 2014, Taylor & Francis

    Dr RAJENDRA AWASTHI, Dr Giriraj T Kulkarni

  140. Development and characterization of amoxicillin loaded floating microballoons for the treatment of Helicobacter pylori induced gastric ulcer

    Article • Asian Journal of Pharmaceutical Sciences, June 2013, Elsevier

    Dr RAJENDRA AWASTHI, Dr Giriraj T Kulkarni

  141. Development of novel gastroretentive drug delivery system of gliclazide: hollow beads

    Article • Drug Development and Industrial Pharmacy, February 2013, Taylor & Francis

    Dr RAJENDRA AWASTHI, Dr Giriraj T Kulkarni

  142. Development of Novel Gastroretentive Floating Particulate Drug Delivery System of Gliclazide

    Article • Current Drug Delivery, August 2012, Bentham Science Publishers

    Dr RAJENDRA AWASTHI, Dr Giriraj T Kulkarni

  143. Optimization Studies on Gastroretentive Floating System Using Response Surface Methodology

    Article • AAPS PharmSciTech, December 2011, American Association of Pharmaceutical Scientists (AAPS)

    Dr RAJENDRA AWASTHI, Dr Giriraj T Kulkarni

  144. Gastroretentive dosage forms: A review with special emphasis on floating drug delivery systems

    Article • Drug Delivery, October 2010, Taylor & Francis

    Dr RAJENDRA AWASTHI, Dr Giriraj T Kulkarni